Infections caused by pathogenic fungi are a significant medical problem, as they are able to
disseminate to nearly every organ of the human body and there are few classes of antifungal …

Since biofilms are ubiquitous in different settings and act as sources of disease for humans,
reliable methods to characterize and quantify these microbial communities are required …

Antifungal therapy is a critical component of patient management for invasive fungal
diseases. Yet, therapeutic choices are limited as only a few drug classes are available to …

Candida albicans and other closely related pathogenic yeast-like fungi carry on their surface
numerous loosely adsorbed “moonlighting proteins”—proteins that play evolutionarily …

Myrcia bella is a medicinal plant used for the treatment of diabetes, hemorrhages, and
hypertension in Brazilian folk medicine. Considering that plant extracts are attractive sources …

Despite several years of research, a lot of questions remain about the paradoxical
attenuation of echinocandin activity against Candida and Aspergillus species at certain drug …

Non-albicans Candida species have been isolated in increasing numbers in patients.
Moreover, they are adept at forming biofilms. This study analyzed biofilm formation of …

Candida species represent the main cause of opportunistic fungal infections worldwide, and
Candida albicans remains the most common etiological agent of candidiasis, now the third …

Abstract Background The Candida glabrata does not develop into a pathogenic hiphal form;
however, it has become the second most common pathogen of fungal infections in humans …

The number of Candida spp. infections and drug resistance are dramatically increasing
worldwide, particularly among immunosuppressed patients, and it is urgent to find novel …